255 results match your criteria: "From Harvard Medical School[Affiliation]"
Harv Rev Psychiatry
May 2019
From Harvard Medical School and Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
In recent years, heightened attention has been paid to commercial sexual exploitation, including domestic human sex trafficking (HST), with mental health concerns named the most dominant health concern among survivors. Human sex trafficking is associated with significant and long-term mental health consequences. Research to date has emphasized ways to identify survivors in health care settings.
View Article and Find Full Text PDFHarv Rev Psychiatry
May 2019
From Harvard Medical School; Department of Psychiatry (Dr. Khoury) and Center for Mindfulness and Compassion (Drs. Lutz and Schuman-Olivier), Cambridge Health Alliance, Cambridge, MA; University of Washington and Seattle Children's Hospital, Seattle, WA (Dr. Khoury).
Interoception, or the process of sensing, interpreting, and integrating internal bodily signals, has increasingly been the subject of scientific research over the past decade but is still not well known in clinical practice. The aim of this article is to review clinical treatment interventions that use interoception, to synthesize the current research knowledge, and to identify the gaps where future research is needed. We conducted a comprehensive literature search on randomized, controlled trials that both include interoception in treatment interventions for individuals with psychiatric disorders and measure aspects of interoception using self-report measures.
View Article and Find Full Text PDFHarv Rev Psychiatry
April 2019
From Harvard Medical School (Drs. Lewis-Schroeder, Murphy, Robinson, and Kaufman) and McLean Hospital, Belmont, MA (all).
First responders are regularly confronted with exposure to traumatic events, including potentially life-threatening situations as well as the grave injuries and deaths of colleagues and civilians. Evidence indicates that the prevalence of posttraumatic stress disorder (PTSD) is substantially higher among first responders than the general population. This article provides information about the outpatient trauma services at McLean Hospital's LEADER (Law Enforcement, Active Duty, Emergency Responder) program to assist clinicians who encounter these first responders in their practices or who are specifically interested in working with this patient population.
View Article and Find Full Text PDFHarv Rev Psychiatry
April 2019
From Harvard Medical School (Drs. Celano, Gaggin, and Huffman); Departments of Psychiatry (Drs. Celano, Villegas, and Huffman, and Ms. Albanese) and Medicine, Division of Cardiology (Dr. Gaggin), Massachusetts General Hospital, Boston, MA.
Learning Objectives: After participating in this activity, learners should be better able to:• Identify the relationships between depression, anxiety, and heart failure (HF).• Assess methods for accurately diagnosing depression and anxiety disorders in patients with HF.• Evaluate current evidence for treatment of anxiety and depression in patients with HF.
View Article and Find Full Text PDFJ Am Acad Orthop Surg
August 2018
From Harvard Medical School, Brigham and Women's Hospital (Dr. Chiodo), Harvard Combined Orthopaedic Residency Program, Massachusetts General Hospital (Dr. Logan), and Harvard Medical School, Spaulding Rehabilitation Hospital and Brigham and Women's Hospital, Boston, MA (Dr. Blauwet).
Orthopaedic surgeons frequently use aspirations and injections to both diagnose and treat disorders of the lower extremity. Comprehensive knowledge of regional anatomy, procedural indications, and appropriate techniques are essential. Clinicians must be well versed in a range of musculoskeletal aspiration and injection techniques, including patient positioning, equipment needs, injectable solutions, aspirate analysis, and potential complications.
View Article and Find Full Text PDFN Engl J Med
May 2018
From Harvard Medical School and Brigham and Women's Hospital, Boston (S.G.T.); and Johns Hopkins University School of Medicine and the Johns Hopkins Hospital, Baltimore (H.R.).
Learning Objectives: After participating in this activity, learners should be better able to:• Evaluate psychotherapeutic and pharmacologic approaches to treating patients with posttraumatic stress disorder.
Abstract: A strong evidence base exists for psychological and pharmacological interventions for the treatment of posttraumatic stress disorder (PTSD). The published literature investigating the effectiveness of these treatments in reducing the symptoms and impairments associated with PTSD has expanded substantially in recent years.
N Engl J Med
April 2018
From Harvard Medical School (A.M., M.E.C.), Beth Israel Deaconess Medical Center (A.M.), and the Harvard T.H. Chan School of Public Health (A.D.S.) - all in Boston.
N Engl J Med
February 2018
From Harvard Medical School and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital - both in Boston.
Harv Rev Psychiatry
June 2019
From Harvard Medical School (Drs. Ionescu, Cusin, Shapero, and Deckersbach); Department of Psychiatry, Massachusetts General Hospital, Boston, MA (all); Athinoula A. Martinos Center for Biomedical Imaging, Boston, MA (Dr. Deckersbach).
Major depressive disorder (MDD) is one of the most prevalent conditions in psychiatry. Patients who do not respond to traditional monoaminergic antidepressant treatments have an especially difficult-to-treat type of MDD termed treatment-resistant depression. Subanesthetic doses of ketamine-a glutamatergic modulator-have shown great promise for rapidly treating patients with the most severe forms of depression.
View Article and Find Full Text PDFAnn Intern Med
January 2018
From Harvard Medical School, Boston; Brigham and Women's Hospital, Boston; Harvard University, Cambridge; and Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Harv Rev Psychiatry
October 2018
From Harvard Medical School (Drs. Adelsky, Wilner, Yudkoff, and Lejeune); Cambridge Health Alliance, Cambridge, MA (Drs. Adelsky and Wilner); Cambridge Hospital, Cambridge, MA (Dr. Adelsky); Departments of Psychiatry and of Neurology and Neurosurgery, McGill University (Dr. Ducharme); Montreal Neurological Institute, Montreal, Quebec (Dr. Ducharme); McGill University Health Centre, Montreal, Quebec (Dr. Ducharme); Brigham and Women's Faulkner Hospital, Boston, MA (Dr. Yudkoff); Mental Health and Counseling, Massachusetts Institute of Technology Health Service, Cambridge, MA (Dr. Lejeune).
Harv Rev Psychiatry
June 2018
From Harvard Medical School; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN (Dr. Darby); Department of Neurology, Massachusetts General Hospital, Boston, MA (Drs. Darby and Dickerson); Berenson-Allen Center for Noninvasive Brain Stimulation, and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Darby).
After participating in this activity, learners should be better able to:• Assess the neuropsychological literature on decision making and the medical and legal assessment of capacity in patients with dementia• Identify the limitations of integrating findings from decision-making research into capacity assessments for patients with dementia ABSTRACT: Medical and legal professionals face the challenge of assessing capacity and competency to make medical, legal, and financial decisions in dementia patients with impaired decision making. While such assessments have classically focused on the capacity for complex reasoning and executive functions, research in decision making has revealed that motivational and metacognitive processes are also important. We first briefly review the neuropsychological literature on decision making and on the medical and legal assessment of capacity.
View Article and Find Full Text PDFRev Assoc Med Bras (1992)
August 2017
Adjunct Professor, Habilitation degree (Livre-docência) in Urology, Escola Paulista de Medicina da Universidade Federal de São Paulo (EPM-Unifesp). Head of the Urologic Oncology Sector at EPM-Unifesp. Graduate degrees from Harvard Medical School and The Johns Hopkins School of Medicine. Member of Academia de Medicina de São Paulo, São Paulo, SP, Brazil.
Screening of prostate cancer with prostate-specific antigen (PSA) is a highly controversial issue. One part of the controversy is due to the confusion between population screening and early diagnosis, another derives from problems related to the quality of existing screening studies, the results of radical curative treatment for low grade tumors and the complications resulting from treatments that affect the patient's quality of life. Our review aimed to critically analyze the current recommendations for PSA testing, based on new data provided by the re-evaluation of the ongoing studies and the updated USPSTF recommendation statement, and to propose a more rational and selective use of PSA compared with baseline values obtained at an approximate age of 40 to 50 years.
View Article and Find Full Text PDFAnn Intern Med
September 2017
From Harvard Medical School, Boston, Massachusetts; National Quality Forum, Washington, DC; and Independent Consultant, New York, New York.
Circulation
July 2017
From Harvard Medical School, Boston, MA (C.M.G.); and University of Edinburgh, Scotland (K.F.).
Harv Rev Psychiatry
October 2018
From Harvard Medical School (Drs. Stephen, Sharma, and Perez, and Ms. Callahan); Movement Disorders Unit (Drs. Stephen and Sharma) and Cognitive Behavioral Neurology Unit (Dr. Perez), Department of Neurology, Massachusetts General Hospital, Boston, MA; Department of Physical Therapy, MGH Institute of Health Professions (Ms. Callahan); Neuropsychiatry Unit, Department of Psychiatry, Massachusetts General Hospital (Dr. Perez); Department of Psychiatry, Department of Clinical Neurosciences, and Department of Rehabilitation Medicine, NHS Lothian and Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Dr. Carson).
Harv Rev Psychiatry
April 2018
From Harvard Medical School (Drs. Spottswood and Huang); Department of Psychiatry, Cambridge Health Alliance (Drs. Spottswood and Huang): Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Dr. Davydow); Institute of Psychiatry & LIM-23, Faculty of Medicine, University of São Paulo (Dr. Huang); Identifying Depression Through Early Assessment Research Team, Urbana, IL (Dr. Huang).
Learning Objectives: After participating in this activity, learners should be better able to:• Determine the prevalence of clinician-diagnosed posttraumatic stress disorder (PTSD) in primary care patients• Identify the prevalence of questionnaire-ascertained PTSD symptoms in primary care patients OBJECTIVE: Determine the prevalence of clinician-diagnosed PTSD and questionnaire-ascertained PTSD symptoms in primary care patients.
Methods: A systematic review of the literature using the PRISMA method, searching MEDLINE, CINAHL, Cochrane Database, PsycINFO, EMBASE, Google Scholar, and relevant book chapter bibliographies. Studies that reported on the prevalence, including point or lifetime prevalence, of PTSD ascertained using diagnostic interviews or self-report questionnaires, or from administrative data, among patients seen in primary care were deemed eligible for inclusion.
Harv Rev Psychiatry
October 2018
From Harvard Medical School; Department of Psychiatry, Boston Children's Hospital, Boston, MA (Drs. Gipson and Maneta); Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Torous).